Comparative clinical study of Amritadi tablet and Arbudhar tablet in the management of Oral Cancer.

Efficacy of Amritadi tablet and Arbudhar tablet as adjuvant therapy in Oral squamous cell carcinoma w.s.r to gutkha induced Oral Cancer-A single blind randomised comparative clinical study.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/06/043204

Enrollment

Registered

2022-06-13

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C069- Malignant neoplasm of mouth, unspecified Health Condition 2: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx Health Condition 3: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx Health Condition 4: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx Health Condition 5: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients with sign and symptoms of squamous cell carcinoma like 1.Mouth ulceration 2.Sore tounge 3.Jaw swelling 4.Pain in the oral cavity 5.Trismus 6.patient diagnosed as squamous cell carcinoma after histopathological report 7.TNM CRITERIA T1N0M0 T2N0M0 T3N0M0 8.Post surgical case

Exclusion criteria

Exclusion criteria: 1.Metastatis 2.Patients suffering from severe systemic disorders and diseases like HIV,Hbsag,STD,TB 3.Uncontrolled DM and HTN 4.Cardiac or Renal disease

Design outcomes

Primary

Measure	Time frame
Subjective criteria:1.Pain in the oral cavity 2.Fatigue 3.Dysphagia 4.Nausea 5.Constipation 6.Diarrhoea 7.Anorexia 8.Irregular bowel habits 9.Flatuence 10.Quality of life Objective criteria:1.Mouth ulceration 2.Trismus 3.Body weightTimepoint: 60 days	—

Secondary

Measure	Time frame
patients condition will be assesed after decrease in sign and symptoms and improve in quality of life.Timepoint: 8 week	—

Countries

India

Contacts

Public ContactDrVipulkumar V Sangani

Government Akhandanand Ayurved College Ahmedabad

drvipulvsangani@gmail.com9998960732

Outcome results